Literature DB >> 30788164

What to expect with major vascular reconstruction during Whipple procedures: a single institution experience and literature review.

Matthew S Jorgensen1, Tariq Almerey2, Houssam Farres1, W Andrew Oldenburg1, John Stauffer2, Albert G Hakaim1.   

Abstract

BACKGROUND: Major vascular reconstruction during a pancreaticoduodenectomy (PD), also known as a Whipple procedure, leads to controversial postoperative outcomes compared to conventional Whipple. Discussion with the patient regarding postoperative expectations is a crucial component of holistic surgical healthcare. The aim of this study was to report our 8-year experience of Whipple procedures involving vascular reconstruction and to review relevant literature to further evaluate expectant outcomes, therefore leading to more accurate discussion.
METHODS: A retrospective review of patients undergoing Whipple procedures from January 2010, through December 2017 was performed. Patch, graft, and primary anastomosis during Whipple procedures were considered major vascular reconstruction. Literature on the current understanding of the outcomes associated with vascular reconstruction during Whipple procedures was reviewed.
RESULTS: Twenty-nine from a total of 405 patients that met inclusion criteria had a Whipple procedure that involved major vascular reconstruction. Twelve patients were male and 17 were female (mean age, 65.2 years). Median hospital and intensive care unit (ICU) stay [range] of patients with vascular reconstruction was 12 [5-92] days and 3 [0-59] days, respectively. Thirty-day survival and 1-year survival of patients with vascular reconstruction was 93.1% and 55.2%, respectively, compared to non-vascular reconstruction patients 96.0% and 83.5%, respectively (P=0.35, P<0.001). Ninety-day readmission for vascular reconstruction patients was 31.0% compared to 14.6% in non-vascular reconstruction patients (P=0.03). The 1-year survival of those who had patch reconstruction, graft reconstruction, and primary anastomosis was 50.0%, 62.5%, 53.8%, respectively.
CONCLUSIONS: Compared to conventional Whipple procedures, those requiring major vascular reconstruction are associated with decreased survival. When vascular reconstruction is a valid option patients should be well aware of the associated outcomes.

Entities:  

Keywords:  Whipple; pancreatic cancer; survival; vascular reconstruction

Year:  2019        PMID: 30788164      PMCID: PMC6351303          DOI: 10.21037/jgo.2018.10.03

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  28 in total

Review 1.  Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?

Authors:  P Bachellier; H Nakano; P D Oussoultzoglou; J C Weber; K Boudjema; P D Wolf; D Jaeck
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

Review 2.  Pancreaticoduodenectomy.

Authors:  Andrew L Warshaw; Sarah P Thayer
Journal:  J Gastrointest Surg       Date:  2004 Sep-Oct       Impact factor: 3.452

3.  Pancreaticoduodenectomy and vascular resection: persistent controversy and current recommendations.

Authors:  Kathleen Christians; Douglas B Evans
Journal:  Ann Surg Oncol       Date:  2009-01-24       Impact factor: 5.344

4.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

5.  En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?

Authors:  Aaron R Sasson; John P Hoffman; Eric A Ross; Steven A Kagan; James F Pingpank; Burton L Eisenberg
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

6.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Authors:  Jennifer F Tseng; Chandrajit P Raut; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Henry F Gomez; Charlotte C Sun; Christopher H Crane; Robert A Wolff; Douglas B Evans
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

7.  Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Kazuaki Shimada; Tsuyoshi Sano; Yoshihiro Sakamoto; Tomoo Kosuge
Journal:  Ann Surg Oncol       Date:  2006-12       Impact factor: 5.344

Review 8.  An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.

Authors:  Alexander Stojadinovic; Ari Brooks; Axel Hoos; David P Jaques; Kevin C Conlon; Murray F Brennan
Journal:  J Am Coll Surg       Date:  2003-06       Impact factor: 6.113

9.  Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor.

Authors:  Isao Kurosaki; Katsuyoshi Hatakeyama; Masahiro Minagawa; Daisuke Sato
Journal:  J Gastrointest Surg       Date:  2007-10-30       Impact factor: 3.452

Review 10.  Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery?

Authors:  Matthias Glanemann; Baomin Shi; Feng Liang; Xiao-Gang Sun; Marcus Bahra; Dietmar Jacob; Ulf Neumann; Peter Neuhaus
Journal:  World J Surg Oncol       Date:  2008-11-12       Impact factor: 2.754

View more
  1 in total

1.  Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma.

Authors:  Yugal Limbu; Sujan Regmee; Roshan Ghimire; Dhiresh Kumar Maharjan; Prabin Bikram Thapa
Journal:  Cureus       Date:  2021-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.